Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: Safety and efficacy

Canadian Journal of Ophthalmology

Volumn 44, Issue 4, 2009, Pages 451-456

  Eid, Tarek M ^a,b   Radwan, Ashraf ^b   El Manawy, Wael ^b   El Hawary, Ihab ^b  

^a TANTA UNIVERSITY   (Egypt)

^b Magrabi Eye and Ear Center   (Saudi Arabia)

Author keywords

Aqueous shunting tube surgery; Bevacizumab; Neovascular glaucoma

Indexed keywords

BEVACIZUMAB;

ABSENCE OF SIDE EFFECTS; ADULT; ANTERIOR EYE CHAMBER; ARTICLE; CHOROID DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EYE MOVEMENT DISORDER; FOLLOW UP; GLAUCOMA DRAINAGE IMPLANT; GRAFT FAILURE; HUMAN; HYPHEMA; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; IRIS BLOOD VESSEL; LASER COAGULATION; NEOVASCULAR GLAUCOMA; PENETRATING KERATOPLASTY; PEROPERATIVE COMPLICATION; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; RECOMMENDED DRUG DOSE; REPEATED DRUG DOSE; TRABECULECTOMY; TREATMENT FAILURE; TREATMENT OUTCOME; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 68149126252     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/i09-108     Document Type: Article

References (18)

1. Sivack-Callcott JA, O'Day DM, Gass DM, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology 2001;108:1767-1776 (Pubitemid 32905930)
2. Oguri A, Takashashi E, Tomita G, Yamamoto T, Jikihara S, Kitazawa Y. Transscleral cyclophotocoagulation with the diode laser for neovascular glaucoma. Ophthalmic Surg Lasers 1998;29:722-727 (Pubitemid 28420662)
3. Bloom PA, Tsai JC, Sharma K, et al. "Cyclodiode". Trans-scleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma. Ophthalmology 1997;104:1508-1519 (Pubitemid 28116821)
4. Mermoud A, Salmon JE, Alexander P, Straker C, Murray AD. Molteno tube implantation for neovascular glaucoma. Longterm results and factors influencing the outcome. Ophthalmology 1993;100:897-902. (Pubitemid 23163501)
5. Sidoti PA, Dunphy TR, Baerveldt G, et al. Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma. Ophthalmology 1995;102:1107-1118
6. Eid TM, Katz LJ, Spaeth GL, Augsburger JJ. Tube-shunt surgery versus neodymium:YAG cyclophotocoagulation in the management of neovascular glaucoma. Ophthalmology 1997;104:1692-1700.
7. Funatsu H, Yamashita H, Sakata K, et al. Vitreous levels of vascular endothelial growth factors and intracellular adhesion molecule 1 are related to diabetic macular edema. Ophthalmology 2005;112:908-916 (Pubitemid 40631499)
8. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-2342 (Pubitemid 38702844)
9. Rosenfeld PJ, Fung AE, Puliafito CA. Optical coherence tomography findings after intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2005;36:336-339 (Pubitemid 41073113)
10. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006;113:363-372
11. Gheith ME, Siam GA, de Barros DS, Garg SJ, Moster MR. Role of intravitreal bevacizumab in neovascular glaucoma. J Ocul Pharmacol Ther 2007;23:487-491 (Pubitemid 350202480)
12. Batioglu F, Astam N, Ozmert E. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma. Int Ophthalmol 2008;28:59-61. (Pubitemid 351308686)
13. Yazdani S, Hendi K, Parkravan M. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma. J Glaucoma 2007;16:437-439 (Pubitemid 47263045)
14. Vatavuk Z, Bencic G, Mandic Z. Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion. Eur J Ophthalmol 2007;17:269-271 (Pubitemid 46918117)
15. Iliev ME, Domig D, Wolf-Schnurrbursch U, Wol S, Sarra GM. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol 2006;142:1054-1056 (Pubitemid 44853889)
16. Kahook MY, Schuman JS, Noecker RJ. Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthalmic Surg Lasers Imaging 2006;37:144-146
17. Tripathi RC, Li J, Tripathi BJ, Chalam KV, Adamis AP. Increased levels of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology 1998;105:232-237 (Pubitemid 28090825)
18. Sone H, Okuda Y, Kawakami Y, et al. Vascular endothelial growth factor level in aqueous humor of diabetic patients with rubeotic glaucoma is markedly elevated (Letter). Diabetes Care 1996;19:1306-1307